Act Now Advisory: New York State's Medical Marijuana Law Gives Workplace Anti-Discrimination Protection

by Epstein Becker & Green
Contact

On July 7, 2014, Governor Andrew Cuomo publicly signed into law New York State's first marijuana legalization law—the Compassionate Care Act ("Act"). The Act (which was actually signed on July 5, 2014, after weeks of behind-closed-doors negotiating between Governor Cuomo and legislators and after many years of effort by patients, physicians, and other advocates) establishes a medical marijuana program. This law sets forth a structure with the goal of providing effective health care by establishing a certification process for patients, practitioners, and other organizations to obtain medical marijuana and identifies covered medical conditions.

Notably, one aspect of the Act has not gained much notoriety. The Act deems those who are covered by the program "disabled" under the New York State Human Rights Law ("NYSHRL"). Although this provision received less publicity, it has obvious impact on the respective rights and obligations of New York employers and workers who are "Certified Patients." As such, the Act clearly has broader implications than merely the legalization of a treatment for certain conditions.

With the passage of the Act, New York became the 23rd state to legalize marijuana for medical purposes. Only eight of the other states, however, have similar anti-discrimination provisions—and even in those other states, the statutory language differs from that of the Act. Therefore, with a dearth of precedent or guidance, it is important to understand the implications of the Act in the employment context.

Overview of the Act

The Act, which became effective immediately following the governor's signature, legalizes non-smokable forms of marijuana for use by patients with certain debilitating medical conditions. While the Act is currently effective, it provides an 18-month grace period for the State to create a certification process for individuals to start receiving medical marijuana.

Certification Process

The New York State Department of Health ("DOH") will set up a registration process for practitioners to issue certification to eligible patients. In order for an individual to become a "Certified Patient," he or she must be:

  • a resident of the State of New York,
  • under the continuing care of a registered practitioner,
  • suffering from one of the covered medical conditions, and
  • likely to receive therapeutic or palliative benefit from the use of medical marijuana.

Certified Patients, or a designated caregiver,[1] will obtain a registry identification card from the DOH upon receiving certification. Certified Patients may obtain the medicinal marijuana from a "Registered Organization." Interestingly, in order to obtain registration, an organization must show that it has entered into a labor peace agreement[2] with a bona fide labor organization representing its employees.

Covered Medical Conditions

A Certified Patient is eligible to use medical marijuana only if he or she has one of the following "Serious Conditions": cancer, positive status HIV or AIDS, amyotrophic lateral sclerosis ("ALS"), Parkinson's disease, multiple sclerosis ("MS"), damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington's disease, or other qualified conditions as added by the Health Commissioner. Within the next 18 months, the Commissioner has the option to add the following conditions as Serious Conditions: Alzheimer's, muscular dystrophy, dystonia, post-traumatic stress disorder, and rheumatoid arthritis.

Use of Medical Marijuana

The Act prohibits the use of medical marijuana in "public places," regardless of a patient's certification status. The definition of a "public place" will be forthcoming in the Commissioner's regulations. It is unclear at this point, however, when the Commissioner will promulgate such regulations.

Additionally, the Act prohibits Certified Patients from smoking marijuana—opting instead for edible, vapor, pill, or oil forms. The acceptable forms of marijuana under the Act were a sticking point for Governor Cuomo, who was adamant that the Act prohibit smoking. The Act also gives the governor the authority to terminate the program, without notice, if the Commissioner or Superintendent of State Police determines that it has created a risk to the public health or safety.

How Does the Act Affect New York Employers?

Under the Act, a Certified Patient is deemed to have a disability under the NYSHRL. Although the federal, New York State, and applicable city laws that prohibit disability discrimination would likely consider such Certified Patients disabled in any event (i.e., without being deemed a Certified Patient), this may not necessarily be the case with future conditions that could be added to the Act as "Serious Conditions."

Indeed, the significance of this aspect of the Act lies in the fact that employees are automatically considered disabled under the NYSHRL. There is little room for factual dispute or interpretation regarding the degree of severity of the condition. Thus, once the question of whether the employee is disabled is no longer at issue, an employer may not discriminate against a Certified Patient based on his or her disability, including, arguably, his or her right to use medical marijuana, so long as such use does not violate applicable law or company policy. Moreover, as with any other disabled employees, the employer must engage in an interactive process to determine if a reasonable accommodation can be made.

Unfortunately, an employer's accommodation obligation is not quite so simple under the Act. In addition to the standard concerns that may arise in determining which reasonable accommodation(s) may be required, the Act itself creates some ambiguity regarding an employer's obligations. For example, as stated earlier, the use of medical marijuana is prohibited in "public places," but that term is currently undefined. So it is not clear whether an employer must accommodate an employee's use of medical marijuana in the workplace.

The term "impaired" is also currently undefined, the significance of which is evident in light of the Act's recognition that marijuana—presently classified as a controlled substance under federal law—can impair an individual who uses it. Indeed, the Act includes a carve-out in its non-discrimination section: Employers may always enforce policies prohibiting employees from performing their duties while impaired by a controlled substance. However, the failure to define "impair" and other important terms in the Act will inevitably result in confusion.

Another brewing issue concerns the apparent conflicting interests in, on the one hand, complying with the Act (and providing accommodations to Certified Patients), and on the other hand, avoiding violations of certain federal laws, such as: (i) the Controlled Substances Act (which continues to classify marijuana as a Schedule I substance for which prescriptions may not be written); (ii) the Drug-Free Workplace Act (which mandates certain federal contractors to provide for a drug-free workplace); and (iii) the Americans with Disabilities Act (which would not bar an employer's adverse action against a Certified Patient who was under the influence at work or was sent for a drug screen). This problem is potentially heightened by the prolonged period during which marijuana metabolites remain in the system of a user. Employers should be mindful of these conflicting laws and, until court decisions or legislation provide clarification, exercise care and caution in making adverse employment decisions.

What Employers Should Do Now

  • Be aware that applicants and employees who are Certified Patients will be considered "disabled" under the NYSHRL.
  • Train managers and human resources employees on how to handle reasonable accommodation requests by disabled employees who are Certified Patients, in particular, where such requests include permitting the employee to utilize medical marijuana.
  • Review policies regarding illegal drugs, drug testing, and disabilities to ensure that each complies with the Act and provides for discipline where an employee's impairment causes an inability to perform the job.
  • Review federal contracts and funding to determine whether an employee's use of medical marijuana under the Act would subject the employer to a claim of violation of such contracts or put funding at risk.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Epstein Becker & Green | Attorney Advertising

Written by:

Epstein Becker & Green
Contact
more
less

Epstein Becker & Green on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!